FDA Commissioner: Patient Safety Must Be Prioritized Over Job CreationFDA commissioner Margaret Hamburg, MD, and regulatory officials from Canada and Europe, said they would not back down from strict oversight of quality at food and drug manufacturing companies despite the suffering economy, according to a Philadelphia Inquirer report.
Dr. Hamburg was joined by Paul Glover of Health Canada and Guido Rasi of the European Medicines Agency at the Drug Information Association's 48th annual meeting.
The FDA was recently scrutinized by Congressional members who believe the agency has impeded job creation by shutting down plants with quality control problems. Dr. Hamburg stressed quality concerns, such as glass shards and metal fractures in tobacco products, could not be ignored by the FDA and other regulators.
Mr. Glover added a universal reporting mechanism could more quickly alert regulators about adverse events and promote patient safety around the world.
More Articles on Patient Safety:AHRQ 2011 State Snapshots Spotlight Healthcare Quality, Population Health
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the free Becker's Operating Room Clinical Quality & Infection Control E-Weekly, which focuses on clinical quality, infection control, patient safety and accreditation, click here.
- Dr. Frank Gerratana Wins 2013 Orthopaedist of the Year Award by The Connecticut Orthopaedic Society
- Dr. Joseph Barmakian Earns Physician Excellence Award for Orthopedics
- The Pain Center of Arizona Receives Phoenix Award From U.S. Commerce Association
- AbbVie, Galapagos Partner to Test Possible Chrohn's Disease Drug
- Making Hand Hygiene Personal: Caregiver-Specific Data to Improve Compliance